| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |